📈 Fed's first cut since 2020: Time to buy the dip? See Tech-focused stock picksUnlock AI Picks

J&J to pay $263 million in New York opioid settlements, avoids trial

Published 06/26/2021, 10:47 AM
Updated 06/26/2021, 11:40 AM
© Reuters. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017.   REUTERS/Mike Blake
JNJ
-

By Jonathan Stempel

NEW YORK (Reuters) -Johnson & Johnson said on Saturday it will pay $263 million to resolve claims it fueled an opioid epidemic in New York state and two of its largest counties.

The settlements remove the drugmaker from a jury trial scheduled to begin on Tuesday on Long Island, where several big opioid makers and distributors are also defendants.

Johnson & Johnson (NYSE:JNJ) did not admit liability or wrongdoing in settling with New York state, and with Nassau and Suffolk counties. The $229.9 million state settlement also calls for J&J to stop selling the painkillers nationwide.

“The opioid epidemic has wreaked havoc" across the nation, New York Attorney General Letitia James said in a statement. "Johnson & Johnson helped fuel this fire."

She said her focus remains "getting funds into communities devastated by opioids as quickly as possible."

J&J said the settlements were consistent with its prior agreement to pay $5 billion to settle opioid claims by states, cities, counties and tribal governments nationwide.

The healthcare company and the largest U.S. drug distributors - AmerisourceBergen (NYSE:ABC) Corp, Cardinal Health Inc (NYSE:CAH) and McKesson Corp (NYSE:MCK) - have proposed paying a combined $26 billion to end thousands of opioid lawsuits.

J&J has also been appealing an Oklahoma judge's 2019 ruling that the New Brunswick (NYSE:BC), New Jersey-based company pay that state $465 million for its deceptive marketing of opioids.

Tuesday's opioids trial is one of several scheduled for this year, with others underway in California and West Virginia.

Drugmakers AbbVie Inc (NYSE:ABBV) and Teva Pharmaceutical Industries (NYSE:TEVA) Ltd and several distributors are among the defendants. Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) Inc is also a defendant, though it was sued only by the counties.

© Reuters. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017.   REUTERS/Mike Blake

Walmart (NYSE:WMT) Inc, Rite Aid (NYSE:RAD) Corp and CVS Health Corp (NYSE:CVS) were severed from the trial during jury selection. CVS has settled with Nassau and Suffolk counties. Settlement terms have not been disclosed.

The U.S. Centers for Disease Control and Prevention has said nearly 500,000 people died from opioid overdoses from 1999 to 2019.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.